catalysts
-
Bullish Free Articles, Bullish Free Videos, Commentary Free Articles, Commentary Free Videos, Free Articles, Free Videos
Why This Small Cap Biotech Is Likely To Rally Soon
In small cap developmental biotech, we see a lot of creative financing, and when we understand how it works, we can profit from it. These types of biotech charts normally trade in a consistent ‘channel pattern.’ and when we spot these patterns, we can profit from them. On January 17th, 2015, 28M shares become unlocked. […]
-
Catalyst Trade Alert *UPDATED With Chart* – Re-Bought Progenics (PGNX) – Price Target Opinion = $6.50
Disclosure: I bought 25k shares of $PGNX @ $5.45 Biorunup’s Mark sold to go on vacation. Sheff remains bullish. we do as well. This is a pure catalyst trade which I talk about in my latest video. If Adcom for Relistor is good, I would expect a price back over $8.50. Progenics has two upcoming […]
-
Bullish Free Articles, Commentary Free Articles, Free Articles
Sunshine Heart’s Pulse System Could Revolutionize How Heart Failure Is Treated
Recent developments in the medical device industry have paved the way for some strong achievements in many different sectors of the health care industry. With regards to heart failure, significant developments date back to the first implantable pacemaker successfully inserted into a patient in 1958. Shortly after, these devices improved and were being used all […]
-
Bullish Free Articles, Commentary Free Articles, Free Articles
The Biotech Merger And Acquisition Buzz List
Merger and acquisition rumors are heard on a daily basis throughout the market. Some have merit and turn out to be true, while others turn out to be false and without merit. Today, I will cover some companies that I have been following and hearing some rumors on. Oftentimes insiders tend to talk and leak […]
-
Bullish Free Articles, Free Articles
Important Upcoming Catalyst For Antares – FDA Decision Expected October 14
n a bit more deliberate than Jazz, but is coming along nicely. Antares started its royalty deals with a gel based platform, one being a royalty deal with Actavis, Inc. (NYSE: ACT) (formely Watson Pharma) for topical oxybutynin gel. Oxybutynin gel is designed to treat overactive bladder, a condition that affects more than 30 million […]
-
Bullish Free Videos, Commentary Free Videos, Free Videos
Video: Halozyme 60 Minute, 10 Day Chart Analysis As Of Close, 9/16/13 – Sentiment = Bullish
Halozyme 60 Minute, 10 Day Chart Analysis As Of Close, 9/16/13 – Sentiment = Bullish
-
Bullish Free Articles, Free Articles
Trius Acquired Last Week, Tetraphase Could Be Next
Written by Scott Matusow, Mr.Matusow holds a position in the company featured in this article. Last week, Cubist Pharmaceuticals Inc. (CBST) agreed to buy Trius Therapeutics Inc. (TSRX) and Optimer Pharmaceuticals Inc. (OPTR) for as much as $1.62 billion. Cubist agreed to merge with Trius for $13.50 a share or about $707 million in cash; […]
-
Bullish Free Articles, Bullish Premium Articles, Free Articles, Premium Articles, Premium Trade Alerts
Significant Near Term Catalyst Should Further Rally Keryx Pharmaceuticals
Recently, we have detailed companies that have released positive Phase III data because we believe several of these companies continue to be under speculation value. Companies who have strong management, cash, and a strong pipeline can be very profitable for investors. Keryx Pharmaceuticals (KERX) is a company that works on developing and commercializing novel therapies […]
-
Commentary Free Articles, Commentary Free Videos, Free Articles, Free Videos
Corrected Video: Market Commentary + Trade Watch Update 7/13/13
Some commentary from me on recent market action plus chart commentary on some of our recent picks. $GTXI $TSRX $SGMO $DRRX $SGMO $FB $BBY
-
Bullish Free Articles, Free Articles
4 Biopharmas On Catalyst Watch List For Week 7/8/2013
Stockmatusow.com has compiled 4 biopharmas with significant near-term catalysts ahead that should drive their respective stock prices higher. We think each of these companies should also be looked at for speculation investments. Since the companies listed below are smaller caps, they carry significant risk. However, if traded properly, they should yield some nice short-term returns […]